Carolinas Wealth Consulting’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-248
| Closed | -$9.61K | – | 382 |
|
|
2025
Q1 | $9.61K | Buy |
248
+20
| +9% | +$775 | ﹤0.01% | 533 |
|
|
2024
Q4 | $7.71K | Sell |
228
-25
| -10% | -$846 | ﹤0.01% | 576 |
|
|
2024
Q3 | $10.4K | Buy |
253
+32
| +14% | +$1.32K | ﹤0.01% | 558 |
|
|
2024
Q2 | $8.51K | Buy |
221
+5
| +2% | +$193 | ﹤0.01% | 580 |
|
|
2024
Q1 | $9.34K | Buy |
216
+8
| +4% | +$346 | ﹤0.01% | 569 |
|
|
2023
Q4 | $7.78K | Buy |
208
+22
| +12% | +$823 | ﹤0.01% | 572 |
|
|
2023
Q3 | $6.64K | Buy |
186
+27
| +17% | +$964 | ﹤0.01% | 574 |
|
|
2023
Q2 | $5.72K | Buy |
159
+56
| +54% | +$2.02K | ﹤0.01% | 662 |
|
|
2023
Q1 | $3.71K | Buy |
103
+3
| +3% | +$108 | ﹤0.01% | 731 |
|
|
2022
Q4 | $3.51K | Buy |
+100
| New | +$3.51K | ﹤0.01% | 737 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 963 |
|
|
2020
Q4 | – | Sell |
-61
| Closed | -$3K | – | 927 |
|
|
2020
Q3 | $3K | Sell |
61
-54
| -47% | -$2.66K | ﹤0.01% | 635 |
|
|
2020
Q2 | $6K | Buy |
+115
| New | +$6K | ﹤0.01% | 377 |
|